Generation of T Cells from Human Embryonic Stem Cell-Derived Hematopoietic Zones1

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Immunology

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0803670PMID 19454684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of T Lineage Cells from Human Embryonic Stem Cells in a Feeder Free System

  2009cited by this paper
• Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues.

  2008cited by this paper
• Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.

  2008cited by this paper
• Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches.

  2008influential reference
• Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors.

  2008cited by this paper
• Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors.

  2008influential reference
• Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors.

  2008cited by this paper
• Notch signaling induces cytoplasmic CD3 epsilon expression in human differentiating NK cells.

  2007cited by this paper
• A human postnatal lymphoid progenitor capable of circulating and seeding the thymus

  2007cited by this paper
• Ontogeny of the hematopoietic system.

  2007influential reference
• Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Functional Human Antigen-Specific T Cells Produced In Vitro Using Retroviral T Cell Receptor Transfer into Hematopoietic Progenitors1

  2007cited by this paper
• Embryonic stem cells make human T cells

  2006cited by this paper
• Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.

  2006influential reference
• Hematopoietic Engraftment of Human Embryonic Stem Cell‐Derived Cells Is Regulated by Recipient Innate Immunity

  2006cited by this paper
• T lineage differentiation from human embryonic stem cells.

  2006cited by this paper
• Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro.

  2005cited by this paper
• Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

  2005cited by this paper
• Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development.

  2005cited by this paper
• New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling

  2005cited by this paper
• CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells.

  2005cited by this paper
• Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment.

  2004cited by this paper
• Development of alphabeta T cells in the human thymus.

  2002cited by this paper
• Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.

  2002influential reference
• Development of αβ T cells in the human thymus

  2002cited by this paper
• Identification of a novel, human multilymphoid progenitor in cord blood.

  2001cited by this paper
• Bone marrow CD34+ cells generate fewer T cells in vitro with increasing age and following chemotherapy

  1999cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants.

  1995cited by this paper
• Differentiation to T helper cells in the thymus. Gradual acquisition of T helper cell function by CD3+CD4+ cells.

  1995cited by this paper

• Generation of TCRγδ + T cells from human embryonic stem cells

  2026cites this paper
• Tunable differentiation of human CD4+ and CD8+ T cells from pluripotent stem cells.

  2026cites this paper
• Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells.

  2025cites this paper
• Dynamic WNT signaling controls differentiation of hematopoietic progenitor cells from human pluripotent stem cells

  2025cites this paper
• Design of soluble Notch agonists that drive T cell development and boost immunity.

  2025cites this paper
• The Application of iPSCs in Tumour Immunotherapy

  2025cites this paper
• Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies

  2025cites this paper
• Regenerative Immunotherapy for Cancer: Transcription Factor Reprogramming of Tumor-Specific T Cells

  2025cites this paper
• Design of a Soluble Multivalent Notch Agonist

  2024cites this paper
• Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation

  2024cites this paper
• Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges

  2024cites this paper
• Stem Cell Therapies Approach for Treating Cancers: Opportunity Progress and Challenges

  2024cites this paper
• Lymphoid cell development from fetal hematopoietic progenitors and human pluripotent stem cells

  2023cites this paper
• Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges

  2023cites this paper
• Analyzing mitochondrial respiration of human induced pluripotent stem cell-derived myeloid progenitors using Seahorse technology

  2023cites this paper
• Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy

  2023cites this paper
• ‘Off the shelf’ immunotherapies: Generation and application of pluripotent stem cell‐derived immune cells

  2023cites this paper
• In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies

  2023cites this paper
• Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs

  2023cites this paper
• Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective

  2023cites this paper
• Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells

  2022cites this paper
• Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review

  2022cites this paper
• Lymphoid Lineage γδ T Cells Were Successfully Generated from Human Pluripotent Stem Cells via Hemogenic Endothelium

  2022cites this paper
• Dendritic Cell Differentiation from Human Induced Pluripotent Stem Cells: Challenges and Progress

  2022cites this paper
• Induced pluripotent stem cells–derived hematopoietic progenitors for cellular immunotherapies

  2022cites this paper
• EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity.

  2022cites this paper
• Off-the-Shelf Chimeric Antigen Receptor Immune Cells from Human Pluripotent Stem Cells.

  2022cites this paper
• BTT_A_368152 89..105

  2022cites this paper
• Stem cell-based multi-tissue platforms to model human autoimmune diabetes

  2022cites this paper
• 3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells.

  2022cites this paper
• Reprogramming cell fates towards novel cancer immunotherapies.

  2022cites this paper
• DLL4 and VCAM1 enhance the emergence of T cell–competent hematopoietic progenitors from human pluripotent stem cells

  2021cites this paper
• Engineering stem cells for cancer immunotherapy.

  2021cites this paper
• Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells

  2021cites this paper
• Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications

  2021cites this paper
• Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells

  2021influential citation
• T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies

  2021cites this paper
• iPSC-derived mucosal-associated invariant T cells

  2021cites this paper
• Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology.

  2021cites this paper
• A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

  2021cites this paper
• Recent Advances in Developmental Hematopoiesis: Diving Deeper With New Technologies

  2021cites this paper
• Modeling of human T cell development in vitro as a read-out for hematopoietic stem cell multipotency

  2021cites this paper
• In vitro T lymphopoiesis

  2021cites this paper
• ‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells

  2021cites this paper
• HIV-1LAI Nef blocks the development of hematopoietic stem/progenitor cells into T lymphoid cells

  2021cites this paper
• Blood components from pluripotent stem cells

  2020cites this paper
• Pluripotent stem cell-derived CD19-CAR iT cells effectively eradicate B-cell lymphoma in vivo

  2020cites this paper
• Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation

  2020cites this paper
• Advances in Cellular Immunotherapy: Understanding and Preventing T-cell Dysfunction

  2020cites this paper
• iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests

  2020cites this paper
• Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications

  2020cites this paper
• Overhauling CAR T Cells to Improve Efficacy, Safety and Cost

  2020cites this paper
• Reprogramming of MAIT Cells to Pluripotency and Redifferentiation.

  2020cites this paper
• Rapid and Reproducible Differentiation of Hematopoietic and T Cell Progenitors From Pluripotent Stem Cells

  2020cites this paper
• Effects of physical exercise on the prevention of stem cells senescence

  2019cites this paper
• Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.

  2019cites this paper
• Application of induced pluripotent stem cell technology for the investigation of hematological disorders.

  2019cites this paper
• Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges

  2019cites this paper
• Future prospects for CD8+ regulatory T cells in immune tolerance

  2019cites this paper
• In Vitro Differentiation of T Cells: From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells.

  2019cites this paper
• NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells

  2019cites this paper
• Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells.

  2019cites this paper
• When CAR Meets Stem Cells

  2019cites this paper
• Hematopoietic Differentiation of Human Pluripotent Stem Cells: HOX and GATA Transcription Factors as Master Regulators

  2019cites this paper
• Toward the development of true “off‐the‐shelf” synthetic T‐cell immunotherapy

  2019cites this paper
• Gene Therapy and Immunosenescence

  2019cites this paper
• Understanding the Journey of Human Hematopoietic Stem Cell Development

  2019cites this paper
• Treg cell-based therapies: challenges and perspectives

  2019cites this paper
• Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.

  2019cites this paper
• From pluripotent stem cells to T cells.

  2019cites this paper
• Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies

  2018cites this paper
• Producing proT cells to promote immunotherapies

  2018cites this paper
• Biphasic modulation of insulin signaling enables highly efficient hematopoietic differentiation from human pluripotent stem cells

  2018cites this paper
• Protagonist or antagonist? The complex roles of retinoids in the regulation of hematopoietic stem cells and their specification from pluripotent stem cells.

  2018cites this paper
• Application of small molecule CHIR99021 leads to the loss of hemangioblast progenitor and increased hematopoiesis of human pluripotent stem cells.

  2018cites this paper
• Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model

  2017cites this paper
• Therapeutic T cell engineering

  2017cites this paper
• Human haematopoietic stem cell development: from the embryo to the dish

  2017cites this paper
• Mitochondria and stem cell function: from somatic cells to iPSC-based disease modeling

  2017cites this paper
• Modelling Human Developmental Hematopoiesis. Towards in vitro Generation of Human Hematopoietic Stem Cells

  2017cites this paper
• Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

  2017cites this paper
• Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential

  2017cites this paper
• Further remarks on potential implementation of the ESC and iPSC technology in clinical practice

  2017cites this paper
• 'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes.

  2017cites this paper
• Hematopoietic Cell Engineering From Human Pluripotent Stem Cells

  2017cites this paper
• Reactive Oxygen Species Impair the Function of CD90+ Hematopoietic Progenitors Generated from Human Pluripotent Stem Cells

  2017cites this paper
• Molecular characterization and expression analysis during embryo development of CD4–1 homologue in large yellow croaker Larimichthys crocea

  2017cites this paper
• Mucosal-Associated Invariant T Cells in Regenerative Medicine

  2017cites this paper
• Pyrimidoindole derivative UM171 enhances derivation of hematopoietic progenitor cells from human pluripotent stem cells.

  2017cites this paper
• Engineering approaches for regeneration of T lymphopoiesis

  2016cites this paper
• Reprogramming away from the exhausted T cell state.

  2016cites this paper
• Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation

  2016cites this paper
• Synthetic Immunology

  2016cites this paper
• GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells

  2016influential citation
• Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects

  2016cites this paper
• Pluripotent stem cell based gene therapy for hematological diseases.

  2016cites this paper
• Generation and Regeneration of T Cells

  2016cites this paper
• Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

  2016cites this paper
• Artificial Thymus: Recreating Microenvironmental Cues to Direct T Cell Differentiation and Thymic Regeneration

  2016cites this paper
• 3. Generation of Definitive Engraftable Hematopoietic Stem Cells from Human Pluripotent Stem Cells

  2016cites this paper